Live Breaking News & Updates on Oxford kidney

Tools on the Horizon for Managing Posttransplant cSCC Risk

Organ transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients.

Yale-university , Connecticut , United-states , San-francisco , California , American , Johns-hopkins , Sean-christensen , Matthew-bottomley , Sarah-arron , Drug-administration , University-of-oxford

Data Make It Clear: SGLT2 Inhibitors Can Be Used in Most Common Kidney Diagnoses, Says Dr William G. Herrington

Data shows sodium-glucose cotransporter-2 (SGLT2) inhibitors are efficacious and can be used in almost all common kidney diagnoses, explained William G. Herrington, MD, MA, MBBS, Nuffield Department of Population Health, University of Oxford.

Williamg-herrington , Nuffield-department-of-population-health , University-of-oxford , Nuffield-department , Population-health , Oxford-kidney , Kidney-week , Diabetes , Kidney-disease , Sglt2-inhibitors , Empagliflozin